Skip to main content

Day: August 11, 2021

Volta Finance Limited: Net Asset Value as at 31 July 2021

Volta Finance Limited (VTA / VTAS) – July 2021 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, 11 August 2021 AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for July. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com). PERFORMANCE and PORTFOLIO ACTIVITY Volta had a good performance in July, gaining +2.5% including a €0.14 dividend. That brings the total return of the fund to 14.1% year-to-date. The monthly asset class performances** were: +1.7% for Bank Balance Sheet transactions, +5.0% for CLO equity tranches; +0.6% for CLO debt; -1.4% for Cash Corporate Credit and ABS (together representing 3.2% of GAV). As expected, July 2021 was a new...

Continue reading

Bayshore successfully hosted its Annual and Special Meeting of Shareholders, August 6, 2021

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ CALGARY, Alberta, Aug. 11, 2021 (GLOBE NEWSWIRE) — Bayshore Petroleum Corp. is pleased to announce it has successfully held its annual general and special meeting (AGSM) on August 6, 2021. The AGSM has approved the following resolutions.(1) Consolidation of Share Capital on the basis of one (1) post-consolidation common shares for each thirty-nine point four five six nine (39.4569) PRE-CONSOLIDATION COMMON SHARES.(2) Change of name from Bayshore Petroleum Corp. to Infinitum Copper Corp.(3) Continuation of the Corporation into the province of British Columbia(4) To fix the number of board members for the Corporation and number of board members conditionally after the closing of the Acquisition(5) Election of current directors...

Continue reading

Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call

ROSELAND, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company’s financial results for the second quarter ended June 30, 2021, as well as the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 1- 844-369-8770 for U.S. callers or 862-298-0840 for international callers. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2306/42492 or on the Company’s website at https://www.milestonescientific.com/. An audio replay of the call will be available through August...

Continue reading

Hermès International : Shares and voting rights as of 31st July 2021

RELEASE Paris, August 11, 2021 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date Total number of shares Total number of theoretical voting rights (including treasury stock) Total number of effective voting rights (exercisable at shareholders’ meetings) Publications31 July 2021 105 569 412 178 454 611 177 529 216 11 August 202130 June...

Continue reading

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

Saint-Herblain (France), August 11th, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced the initiation of a further Phase 3 trial (VLA2001-304) for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001-304 aims to generate data in the elderly and is also designed to potentially enable variant-bridging through immune-comparability. Data from this study are expected to complement ongoing clinical trials and support additional regulatory submissions. VLA2001-304, which will be conducted in New Zealand, will recruit approximately 150 participants aged 56 years and older (Cohort 1) with the aim of generating additional safety and immunogenicity...

Continue reading

Dominion Lending Centres Inc. Announces Q2-2021 Earnings Release Date

VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSXV:DLCG) (“DLCG” or the “Corporation”) is pleased to announce that it will release its financial results for the three and six months ended June 30, 2021, on August 23, 2021, after the market close. About Dominion Lending Centres Inc. The DLC Group is Canada’s leading network of mortgage professionals. The DLC Group operates through Dominion Lending Centres and its three main subsidiaries, MCC Mortgage Centre Canada Inc., MA Mortgage Architects Inc. and Newton Connectivity Systems Inc., and has operations across Canada. The DLC Group’s extensive network includes ~7,000 agents and 515 locations. Headquartered in British Columbia, the DLC Group was founded in 2006 by Gary Mauris and Chris Kayat. Contact information for the Corporation is...

Continue reading

Brookfield Infrastructure Reminds Inter Pipeline Shareholders to Tender to the Board Recommended Offer – Offer Open Until August 20th at 5 p.m. (Mountain Time)

Inter Pipeline Ltd. (“IPL”) shareholders who tender to the Offer will remain eligible to receive IPL’s August cash dividend1 IPL shareholders must tender their shares by August 20th to receive the significant premium available under Brookfield Infrastructure’s Offer IPL shareholders that have already tendered do not need to take any further action Given the 52% initial tender results and tenders that continue to be received, Brookfield Infrastructure is confident the modified statutory minimum condition will be met Questions or Need Assistance? Contact Laurel Hill Advisory Group at 1-877-452-7184 or email assistance@laurelhill.comBROOKFIELD, News, Aug. 11, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional partners (collectively, “Brookfield Infrastructure”)...

Continue reading

H1 2021 Interim Financial Report: solid demand across all markets led to strong organic growth and historical high earnings

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first half of 2021 (“H1 2021”). CEO Michael T. Andersen quote “Our markets have quickly recovered from the slowdown seen in early in the year caused by harsh weather conditions and Q2 2021 has showed solid demand across all markets leading to strong organic growth and historical high earnings for H+H—both for the quarter and for the half-year period. The UK market in particular has showed very strong demand and H+H is producing at near-full capacity to service its customers. Germany continues to provide a strong and stable market for H+H and in Poland, increasing demand appears to have stabilised the competitive situation in the CSU business and price increases have been observed in certain...

Continue reading

Ultimovacs ASA: Invitation to second quarter 2021 results webcast presentation

Oslo, 11 August 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, invites to a webcast presentation of its second quarter 2021 results on Friday 20 August 2021. The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210820_5) at 09:00 CET on Friday 20 August 2021. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast. The report and presentation will be available on the company website from 08:00 CET the same day. For further information, please see www.ultimovacs.com or contact: Carlos de Sousa, CEO Email: carlos.desousa@ultimovacs.comPhone: +47 908 92507 Hans Vassgård Eid, CFO Email: hans.eid@ultimovacs.comPhone:...

Continue reading

Brunswick Corporation Announces Expiration of Any and All Tender Offers

METTAWA, Ill., Aug. 11, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) (“Brunswick”) today announced the expiration of its previously announced tender offers (the “Tender Offers”) to purchase for cash any and all of its outstanding 7.375% Debentures due 2023 (the “7.375% Debentures”) and 7.125% Notes due 2027 (the “7.125% Notes” and, together with the 7.375% Debentures, the “Securities”). The following table sets forth specified terms of the Tender Offers:Title of Security Security Identifiers Principal Amount Outstanding Reference U.S. Treasury Security Principal Amount Tendered (percent of Principal Amount Outstanding)(1)7.375% Debentures due 2023 CUSIP: 117043AE9 ISIN: US117043AE96 $ 103,071,000 0.125% UST due 07/31/2023 $23,370,000 (22.67%)7.125% Notes due 2027 CUSIP: 117043AG4 ISIN: US117043AG45 $ 163,265,000 0.625%...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.